Genentech News
Most Popular Genentech Story
Roche, Pfizer cancer meds fail trials
Talk about a double whammy: Two big cancer drugs failed late-stage trials that could have broadened their use considerably. Roche's Avastin didn't make the grade against prostate cancer, failing to... Read more...
Latest Headlines
- March 15, 2010
- March 12, 2010
- February 3, 2010
- February 2, 2010
- January 12, 2010
- December 14, 2009
- November 16, 2009
- October 28, 2009
- October 19, 2009
- October 14, 2009
- October 13, 2009
- October 9, 2009
- October 2, 2009
- September 17, 2009
- September 14, 2009
- August 28, 2009
- August 18, 2009
- July 10, 2009
- May 20, 2009
- May 12, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
